Clinical Trials Logo

Clinical Trial Summary

The Austrian Myeloid Registry (aMYELOIDr) is a non-interventional study. It collects data from patients with the myeloid diseases, primarily myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).The aMYELOIDr is multi-center database collecting data at various sites in Austria and potentially also at other centers in other countries in future. The registry has an electronic case report form (eCRF), where all data is entered by clinical trial personnel and/or physicians. It is set up to collect real-world experience in the management of patients with these diseases in Austria.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04438889
Study type Observational [Patient Registry]
Source Arbeitsgemeinschaft medikamentoese Tumortherapie
Contact Lisa Pleyer, MD
Phone +43676899758271
Email dr.lisa.pleyer@gmail.com
Status Recruiting
Phase
Start date July 13, 2020
Completion date April 2030

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03531736 - T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia Phase 1
Recruiting NCT05552469 - Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases Phase 1